ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 2604

$638K Total Retail Price of All Prescriptions

Rank: 103 out of 2604

309 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 309 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

52% of this provider’s 309 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,072 314 S3 1 1
FUROSEMIDE 496 338 2 8
SIMVASTATIN 284 162 3 2
OMEPRAZOLE 264 103 4 5
ATENOLOL 263 108 5 11
LEVOTHYROXINE SODIUM 233 115 6 4
GABAPENTIN 187 43 7 12
POTASSIUM CHLORIDE 170 116 8 16
METOPROLOL TARTRATE 150 124 9 9
LISINOPRIL 141 57 10 3
TRAMADOL HCL 137 40 11 15
FAMOTIDINE 136 81 12 68
RANITIDINE HCL 129 28 13 25
SINGULAIR 128 68 14 120
METFORMIN HCL 128 38 14 7
WARFARIN SODIUM 127 77 16 13
AMLODIPINE BESYLATE 126 78 17 6
AZITHROMYCIN 125 43 18 33
ISOSORBIDE MONONITRATE ER 119 89 19 38
ZOLPIDEM TARTRATE 117 41 20 21
CYCLOBENZAPRINE HCL 115 28 R 21 43
CARVEDILOL 111 67 22 26
METHYLPREDNISOLONE 109 32 23 112
AMITRIPTYLINE HCL 106 44 R 24 82
TRICOR 106 43 24 132
GLIPIZIDE 104 66 26 51
ENALAPRIL MALEATE 100 64 27 50
LEVOFLOXACIN 97 61 28 113
CITALOPRAM HBR 94 61 29 18
DONEPEZIL HCL 84 84 30 28
MONTELUKAST SODIUM 84 50 30 213
MORPHINE SULFATE ER 83 0 S2 32 58
PREDNISONE 81 40 33 34
CARISOPRODOL 80 0 R 34 54
FENTANYL 75 20 S2 35 48
CLONIDINE HCL 75 26 35 56
NAMENDA 73 73 37 37
QUETIAPINE FUMARATE 73 43 37 66
CIPROFLOXACIN HCL 72 25 39 59
SERTRALINE HCL 70 17 40 23
NAPROXEN 69 19 41 76
OXYCODONE HCL-ACETAMINOPHEN 67 0 S2 42 106
METOLAZONE 67 51 42 231
CEPHALEXIN 65 40 44 74
IBUPROFEN 65 0 44 32
CLOPIDOGREL 64 46 46 39
NYSTATIN 61 39 47 100
LIDODERM 60 31 48 80
KLOR-CON M20 59 39 49 86
MIRTAZAPINE 57 45 50 52
LOVAZA 56 36 51 146
KLOR-CON 8 56 40 51 392
LANTUS 55 11 53 40
CELEBREX 50 0 54 114
ATORVASTATIN CALCIUM 50 31 54 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.